Based on the UDG Healthcare plc's performance during the first quarter of the financial year and the taxation benefit, the Group expects constant currency adjusted diluted earnings per share (EPS) for the year to 30 September 2018 to be between 18% to 21% ahead of last year's EPS of 37.1 US cents. The Group expects that given the additional Future Fit operating costs during the first half of the year and the phasing of Sharp's growth, fiscal year underlying profit growth will be largely delivered during the second half of the year. Based on preliminary analysis, the effective Group tax rate for fiscal year 2018 is expected to be 4% lower than previously anticipated at approximately 19%.